Pedro Gutiérrez-Castrellón1,5*, Juan M.A. Garcia-Lara2, Diana M. Andrade-Platas1,2, Bradley Robinson5 and Jonathan RT Lakey1,4,5*
Efficacy and Safety of Tesamorelin for Hepatic Steatosis in Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease a Systematic Review, Random-Effects Meta-Analysis and Placebo-Anchored Network Meta-Analysis with SUCRA Ranking
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide, yet the pharmacological armamentarium remains narrow and only one ..

